Related Experiment Video
Updated: Jul 2, 2026

12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
Validation of quality indicators for radical prostatectomy.
Ellen O M Chan1, Patti A Groome, D Robert Siemens
1Division of Cancer Care and Epidemiology, Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.
International Journal of Cancer
|August 20, 2008
Summary
This study assessed radical prostatectomy quality indicators using patient charts. Some indicators were unavailable, but 3 showed validity, correlating with hospital volume and aiding quality improvement in early prostate cancer care.
Area of Science:
- Urology
- Health Services Research
- Surgical Quality
Background:
- Quality indicators for radical prostatectomy are crucial but their feasibility and validity are understudied.
- Assessing quality indicators requires evaluating data availability and correlation with established quality markers like hospital volume.
Purpose of the Study:
- To assess the feasibility and validity of proposed quality indicators for radical prostatectomy.
- To test the convergent construct validity of available indicators against hospital prostatectomy volume.
Main Methods:
- Assessed availability of 9 candidate quality indicators from treating charts of 645 prostate cancer patients.
- Tested validity of available indicators by correlating them to hospital prostatectomy volume.
- Analyzed outcomes such as blood transfusions, hospital stay, surgical technique, complication rates, and margin status.
Main Results:
- Four of 9 quality indicators were unavailable for 25-56% of patients.
- Worse outcomes (transfusions, hospital stay, non-nerve-sparing technique) were associated with lower hospital volume.
- Convergent construct validity was demonstrated for 3 quality indicators.
Conclusions:
- Missing data limits the feasibility of some radical prostatectomy quality indicators.
- Validated indicators using readily available information can help identify areas for improvement in early prostate cancer management.
- Further validation may enable broader application for quality improvement initiatives.